Public Health Management of Humans at Risk

Rabies

Volumn , Issue , 2003, Pages 401-428

  Briggs, Deborah J ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0038017981     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012379077-4/50014-6     Document Type: Chapter

References (102)

1. Adle-Biassette H., Bourhy H., Gisselbrecht M., Chretien F., Wingertsmann L., Baudrimont M., Rotivel Y., Godeau B., Gray F. Rabies encephalitis in a patient with AIDS: A clinicopathological study. Acta. Neuropathol. 1996, 92:415-420.
2. Arguin P.M., Krebs J.W., Mandel E., Guzi T., Childs J.E. Survey of rabies preexposure and postexposure among missionary personnel stationed outside the United States. J. Travel Med. 2000, 7:10-14.
3. Bernard K.W., Fishbein D.B. Pre-exposure rabies prophylaxis for travellers: Are the benefits worth the cost?. Vaccine 1991, 9:833-836.
4. Bernard K.W., Fishbein D.B., Miller K.D., Parker R.A., Waterman S., Sumner J.W., Feid F.L., Johnson B.K., Rollins A.J., Oster C.N., Schonberger L.B., Baer G.M., Winkler W.G. Pre-exposure rabies immunization with human diploid cell vaccine: Decreased antibody responses in persons immunized in developing countries. Am. J. Trop. Med. Hyg. 1985, 34:633-647.
5. Bernard K.W., Mallonee J., Wright J.C., Reid F.L., Makintubee S., Parker R.A., Dwyer D.M., Winkler W.G. Preexposure immunization with intradermal human diploid cell rabies vaccine. JAMA 1987, 257:1059-1063.
6. Bhanganada K., Wilde H., Sakolsataydorn P., Oonsombat P. Dog-bite injuries at a Bangkok teaching hospital. Acta Tropica 1993, 55:249-255.
7. Bjorvatn B., Gundersen S.G. Rabies exposure among Norwegian missionaries working abroad. Scand. J. Infect. Dis. 1980, 12:257-264.
8. Briggs D.J., Banzhoff A., Nicolay U., Sirikwin S., Dumavibhat B., Tongswas S., Wasi C. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero cell rabies vaccine. Bull. WHO 2000, 78:693-698.
9. Briggs D.J., Dreesen D.W., Nicolay U., Chin J.E., Davis R., Gordon C., Banzhoff A. Purified chick embryo cell culture rabies vaccine: Interchangeability with human diploid cell culture rabies vaccine and comparison of a one-dose versus two-dose post-exposure booster regimen for previously immunized persons. Vaccine 2001, 19:1055-1060.
10. Briggs D.J., Schwenke J.R. Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. Vaccine 1992, 10:125-129.
11. Burridge M.J., Gaer G.M., Sumner J.W., Sussman O. Intradermal immunization with human diploid cell rabies vaccine. JAMA 1982, 248:1611-1614.
12. CDC Human rabies-Kenya. Morbid. Mortal. Weekly Rep. 1983, 32:494-495.
13. CDC Human rabies-Montana and Washington. Morbid. Mortal Weekly Rep. 1997, 46:770-774.
14. CDC Human rabies-Texas and New Jersey. Morbid. Mortal. Weekly Rep. 1998, 47:1-5.
15. CDC Human rabies-Virginia, 1998. Morbid. Mortal. Weekly Rep. 1998, 48:95-97.
16. CDC Human rabies prevention-United States, 1999. Recommendations of the advisory Committee on Immunization Practices (ACIP). Morbid. Mortal. Weekly Rep. 1999, 48(RR-1):1-21.
17. CDC Public health response to a potentially rabid bear cub-Iowa, 1999. Morbid. Mortal. Weekly Rep. 1999, 48:971-973.
18. CDC Mass treatment of humans who drank unpasteurized milk from rabid cows-Massachusetts, 1996-1998. Morbid. Mortal. Weekly Rep. 1999, 48:228-229.
19. Chomel B.B. Rabies exposure and clinical disease in animals. Rabies: Guidelines for Medical Professionals 1999, 20-26. Veterinary Learning Systems, Trenton, NJ.
20. Chutivongse S., Wilde H. Postexposure rabies vaccination during pregnancy: Experience with 21 patients. Vaccine 1989, 7:546-548.
21. Chutivongse S., Wilde H., Benjavongkulchai M., Chomchey P., Punthawong S. Postexposure rabies vaccination during pregnancy: Effect on 202 women and their infants. Clin. Infect. Dis. 1995, 20:818-820.
22. Chutivongse S., Wilde H., Supich C., Baer G.M., Fishbein D.B. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 1990, 335:896-898.
23. Coleman P.G., Dye C. Immunization coverage required to prevent outbreaks of dog rabies. Vaccine 1996, 14:85-186.
24. Conomy J.P., Leibovitz A., McCombs W., Stinson J. Airborne rabies encephalitis: Demonstration of rabies virus in the human central nervous system. Neurology 1977, 27:67-69.
25. Constantine D.G. Rabies transmission by nonbite route. Public Health Rep. 1962, 77:287-289.
26. Dean D.J., Baer G.M. Studies on the local treatment of rabies-infected wounds. Bull. WHO 1963, 28:477-486.
27. Deshpande A., Briggs D.J., Banzhoff A. Investigation of immune resonse to purified chick embryo cell tissue culture rabies vaccine (PCECV) in HIV infected individuals using a simulated post-exposure regimen. XIII International AIDS Conference 2000, 163-167.
28. Dreesen D.W., Bernard K.W., Parker R.A., Deutsch A.J., Brown J. Immune complex-like disease in 23 persons following a booster dose of rabies human diploid cell vaccine. Vaccine 1986, 4:45-49.
29. Dreesen D.W., Fishbein D.B., Kemp D.T., Brown J. Two-year comparative trial on the immunogenicity and adverse effects of purified chick embryo cell rabies vaccine for pre-exposure immunization. Vaccine 1989, 7:397-400.
30. Dutta A.K., Kanwal S.K. Rabies and its prevention. J. Assoc. Prevent. Control Rabies India 1999, 1:5-13.
31. Eng T.R., Fishbein D.B. National study group on rabies: Epidemiologic factors, clinical findings and vaccination status of rabies in cats and dogs in the United States in 1988. J. Am. Vet. Med. Assoc. 1990, 197:201-209.
32. Fekadu M., Endeshaw T., Alemu W., Bogale Y., Teshager T., Olson J.G. Possible human-to-human transmission of rabies in Ethiopia. Ethiop. Med. J. 1996, 34:123-127.
33. Fescharek R., Schwarz S., Quast U., Gandhi N., Karkhanis S. Postexposure rabies prophylaxis: When the guidelines are not respected. Vaccine 1991, 9:868-872.
34. Fishbein D.B., Bernard K.W., Miller K.D., Van der Vlugt T., Gaines C.E., Bell J.T., Sumner J.W., Reid F.L., Parker R.A., Horman J.T., Pinsky P.F., Schonberger L.B., Baer G.M., Winkler W.G. The early kinetics of the neutralizing antibody response after booster immunizations with human diploid cell rabies vaccine. Am. J. Trop. Med. Hyg. 1986, 35:663-670.
35. Fishbein D.B., Pacer R.E., Holmes D.F., Ley A.B., Yager P., Tong T.C. Rabies preexposure prophylaxis with human diploid cell rabies vaccine: A dose-response study. J. Infect. Dis. 1987, 156:50-55.
36. Fishbein D.B., Sawyer L.A., Reid Sanden F.L., Weir E.H. Administration of human diploid-cell rabies vaccine in the gluteal area. New Engl. J. Med. 1988, 318:124-125.
37. Fishbein D.B., Yenne K.M., Dreesen D.W., Teplis C.F., Mehta N., Briggs D.J. Risk factors for systemic hypersensitivity reactions after booster vaccinations with human diploid cell rabies vaccine: A nationwide prospective study. Vaccine 1993, 11:1390-1394.
38. Fleisher G.R. The management of bite wounds. New Engl. J. Med. 1999, 340:138.
39. Foster R., Briggs D.J. Pre-exposure immune response of persons receiving purified chick embryo cell vaccine while receiving the anti-malarial drug mefloquine (Abstract). X International Meeting for the Advancement of the Investigation and Control of Rabies in the Americas Meeting 1999.
40. Fraser G.C., Hooper P.T., Lunt R.A., Gould A.R., Gleeson L.J., Hyatt A.D., Russell G.M., Kattenbelt J.A. Encephalitis caused by a Lyssavirus in fruit bats in Australia. Emerg. Infect. Dis. 1996, 2:327-331.
41. Fuenzalida E., Palacios R., Borgono J.M. Anti-rabies antibody response in man to vaccine made from infected suckling-mouse brains. Bull WHO 1964, 30:431-436.
42. Gerrard J. Fatal encephalitis and meningitis at the Gold Coast Hospital, 1980-1996. Commun. Dis. Intell. 1997, 6:32-33.
43. Halpin K., Young P.L., Field H., Mackenzie J.S. Newly discovered viruses of flying foxes. Vet. Microbiol. 1999, 16:83-87.
44. Hanlon C.A., Childs J.E., Nettles V.F. Article III: Rabies in wildlife. J. Am. Vet. Med. Assoc. 1999, 215:1612-1617.
45. Hanna J.N., Camey I.K., Smith G.A. Australian bat lyssavirus infection: A second human case, with a long incubation period. Med. J Aust. 2000, 172:597-599.
46. Hatchett R.P. Rabies: The disease and the value of intensive care treatment. Intensive Care Nurs. 1991, 7:53-60.
47. Hatz C.F., Bidaus J.M., Eichenberger K., Mikulics U., Junghanss T. Circumstances and management of 72 animal bites among long-term residents in the tropics. Vaccine 1995, 13:811-815.
48. Haupt W. Rabies-Risk of exposure and current trends in prevention of human cases. Vaccine 1999, 17:1742-1749.
49. Heath S.E., Chomel B.B. Risk factors, prevention and prophylaxis of dog bites for disaster response personnel in the United States. Prehosp. Disaster Med. 1998, 13:133-136.
50. Helmick C.G., Tauxe R.V., Vernon A.A. Is there a risk to contacts of patients with rabies?. Rev. Infect. Dis. 1987, 9:511-517.
51. Hemachudha T., Griffin D.E., Giffels J.J., Johnson R.T., Moser A.B., Phanuphak P. Myelin basic protein as an encephalitogen in encephalomyelitis and polyneuritis following rabies vaccination. New Engl. J. Med. 1987, 316:369-373.
52. Jaiiaroensup W., Lanag J., Thipkong P., Wimalaratne O., Samranwataya P., Saikasem A., Chareonwai S., Yenmuang W., Prakongsri S., Sitprija V., Wilde H. Safety and efficacy of purified Vero cell rabies vaccine given intramuscularly and intradermally: Results of a prospective randomized trial. Vaccine 1998, 16:1559-1562.
53. Javadi M.A., Fayaz A., Mirdehghan S.A., Ainollahi B. Transmission of rabies by corneal graft. Cornea 1996, 15:431-433.
54. John T.J. An ethical dilemma in rabies immunisation. Vaccine 1997, 15:S12-S15.
55. Kaplan M.M., Cohen D., Koprowski H., Dean D., Ferrigan L. Studies on the local treatment of wounds for the prevention of rabies. Bull. WHO 1962, 26:765-775.
56. Khawplod P., Wilde H., Chomchey P., Benjavongkulchai M., Yenmuang W., Chaiyabutr N., Sitprija V. What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously?. Vaccine 1996, 14:389-391.
57. King A.A., Turner G.S. Rabies: A review. J. Comp. Pathol. 1993, 108:1-39.
58. Krause E., Grundmann H., Hatz C. Pretravel advice neglects rabies risk for travelers to tropical countries. J. Travel Med. 1999, 6:163-167.
59. Krebs J.W., Rupprecht C.R., Childs J.E. Rabies surveillance in the United States during 1999. J. Am. Vet. Med. Assoc. 2000, 217:1799-1811.
60. Lang J., Gravenstein S., Briggs D., Miller B., Froeshle J., Dukes C., Le Mener V., Lutsch C. Evaluation of the safety and immunogenicity of a new, heat-treated human rabies immune globulin using a sham, post-exposure prophylaxis of rabies. Biologicals 1998, 26:7-15.
61. Lang J., Simanjuntak G.H., Soerjosembodo S., Koesharyono C. Suppressant effect of human or equine rabies immunoglobulins on the immunogenicity of post-exposure rabies vaccination under the 2-1-1 regimen: A field trial in Indonesia. Bull. WHO 1998, 76:491-495. MAS054 clinical Investigator Group.
62. Lau J. Intradermal rabies vaccination and current use of mefloquine. J. Travel Med. 1999, 6:140-141.
63. Lopez A.R., Miranda P.P., Tejada E.V., Fishbein D.B. Outbreak of human rabies in the Peruvian jungle. Lancet 1992, 339:408-411.
64. Moore D.A., Sischo W.M., Hunter A., Miles T. Animal bite epidemiology and surveillance for rabies postexposure prophylaxis. JAMA 2000, 217:190-194.
65. Moran G.J., Talan D.A., Mower W., Newdow M., Ong S., Nakase J.Y., Pinner R.W., Childs J.E. Appropriateness of rabies postexposure prophylaxis treatment for animal exposures. JAMA 2000, 284:1001-1007.
66. Murray K.O., Arguin P.M. Decision-based evaluation of recommendations for preexposure rabies vaccination. J. Am. Vet. Med. Assoc. 2000, 216:188-191.
67. Compendium of animal rabies, prevention and control, 2001. J. Am. Vet. Med. Assoc. 2001, 218:26-31. National Association of State Public Health Veterinarians.
68. Neizgoda M., Briggs D.J., Shaddock J., Dreesen D.W., Rupprecht C.E. Rabies pathogenesis in the domestic ferret. Am. J. Vet. Res. 1997, 58:1327-1331.
69. Niezgoda M., Briggs D.J., Shaddock J., Rupprecht C. Viral excretion in domestic ferrets (Mustela putorius furo) inoculated with a raccoon rabies isolate. Am. J. Vet. Res. 1998, 59:1629-1632.
70. Noah D.L., Drenzek C.L., Smith J.S., Krebs J.W., Orciari L., Shaddock J., Sanderlin D., Whitfield S., Fekadu M., Olson J.G., Rupprecht C.R., Childs J.E. Epidemiology of human rabies in the United States, 1980 to 1996. Ann. Intern. Med. 1998, 128:922-929.
71. Pan American Health Organization/World Health Organization XI Inter-American Meeting, at the Ministerial Level, on Animal Health. Regional Program for the Elimination of Human Rabies Transmitted by Dogs in the Americas: Analysis of Progress 1990-1998 1999.
72. Pappaioanou M., Fishbeinn D.B., Dreesen D.W., Schwartz I.K., Campbell G.H., Sumner J.W., Patchen L.C., Brown W.J. Antibody response to preexposure human diploid-cell rabies vaccine given concurrently with chloroquine. New Engl. J. Med. 1986, 314:280-284.
73. Parviz S., Luby S., Wilde H. Postexposure treatment of rabies in Pakistan. Clin. Infect. Dis. 1998, 27:751-756.
74. Pasteur L. Méthode pour prévenir la rage après morsure. C. R. Acad. Sci. (Paris) 1885, 101:765-774.
75. Phanuphak P., Ubolyam S., Sirivichayakul S. Should travellers in rabies endemic areas receive pre-exposure rabies immunization?. Ann. Med. Interne (Paris) 1994, 145:167-176.
76. Plotkin S.A., Rupprecht C.R., Koprowski H. Rabies vaccine. Vaccines 1999, 743-766. W. B. Saunders, Philadelphia. 3rd ed. S.A. Plotkin, W.A. Orenstein (Eds.).
77. Reddy A.V., Sampath G. Post exposure treatment: Some experiences. J. Assoc. Prevent. Control Rabies India. 2000, 1:33-35.
78. Remington P.A., Shope T., Andrews J. A recommended approach to the evaluation of human rabies exposure in an acute-care hospital. JAMA 1985, 254:67-69.
79. Report on the Global HIV/AIDS Epidemic, June 1998 1999, World Health Association and Joint United Nations Programme on HIV/AIDS.
80. Rotz L.D., Hensley J.A., Rupprecht C.E., Childs J.E. Large-scale human exposures to rabid or presumed rabid animals in the United States: 22 cases (1990-1996). J. Am. Vet. Med. Assoc. 1998, 212:1198-1200.
81. Sabchareon A., Chantavanich P., Pasuralertsakul S., Pojjaroen-Anant C., Prarinyanupharb V., Attanath P., Singhasivanon V., Buppodom W., Lang J. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunizations with purified Vero cell rabies vaccine. Pediatr. Infect. Dis. J. 1998, 17:1001-1007.
82. Shankar S.K., Madhusudana S.N., Satyanarayana S.H. Pathological morbidity following Semple type antirabies vaccine in India and why we need to replace it. J. Assoc. Prevent. Control Rabies India 2000, 1(2):15-20.
83. Shill M., Baynes R.D., Miller S.D. Fatal rabies encephalitis despite appropriate post-exposure prophylaxis. New Engl. J. Med. 1987, 316:1257-1258.
84. Sudarshan M.K., Madhusudana S.N., Mahendra B.J. Post-exposure prophylaxis with purified Vero cell rabies vaccine during pregnancy: Safety and immunogenicity. J. Commun. Dis. 1999, 31:229-236.
85. Sureau P., Ravisse P., Rollin R.E. Rabies diagnosis by animal inoculation, identification of Negri bodies, or ELISA. The Natural History of Rabies 1991, 204-217. CRC Press, Boca Raton, FL. 2nd ed. G.M. Baer (Ed.).
86. Swaddiwudhipong W., Prayoonwiwat N., Kunasol P., Choomkasien P. A high incidence of neurological complications following Semple anti-rabies vaccine. SE Asian J. Trop. Med. Public Health 1987, 18:526-531.
87. Swanson M.C., Rosanoff E., Gurwith M., Deitch M., Schnurrenberger P., Reed C.E. IgE and IgG antibodies to β-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine. J. Infect. Dis. 1987, 155:909-913.
88. Thisyakorn U., Pancharoen C., Ruxrungtham K., Ubolyam S., Khawplod P., Tantawichien T., Phanuphak P., Wilde H. Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1. Clin. Infect. Dis. 2000, 30:218.
89. Trimarchi C.V., Briggs D.J. The diagnosis of rabies. Rabies: Guidelines for Medical Professionals 1999, 55-66. Veterinary Learning Systems, Trenton, NJ.
90. Varner M.W., McGuinness G.A. Rabies vaccination in pregnancy. Am. J. Obstet. Gynecol. 1982, 143:717-718.
91. Vodopija I., Clark H.F. Human vaccination against rabies. The Natural History of Rabies 1991, 571-595. CRC Press, Boca Raton, FL. 2nd ed. G.M. Baer (Ed.).
92. Vodopija R., Lafon M., Baklaic Z., Ljubicic M., Svjetlicic M., Vodopija I. Persistence of humoral immunity to rabies 1100 days after immunization and effect of a single booster dose of rabies vaccine. Vaccine 1997, 5:571-574.
93. Vodopija R., Sureau P., Smerdel S., Lafon M., Baklaic Z., Ljubicic M., Svjetlicic M. Interaction of rabies vaccine with human rabies immunoglobulin and reliability of a 2-1-1 schedule application for postexposure treatment. Vaccine 1988, 6:283-286.
94. Warrell M.J., Nicholson K.G., Warrell D.A., Suntharasamai P., Chanthavanich P., Viravan C., Sinhaseni A., Cheiwbamroongkiat M., Pouradier-Duteil X., Xueref C., Phangfung R., Udomsakdi D. Economical multiple-site intradermal immunization with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1985, i:1059-1062.
95. Wasi C., Chaiprasithikul P., Thongcharoen P., Choomkasien P., Sirikawin S. Progress and achievement of rabies control in Thailand. Vaccine 1997, 15:S7-S11.
96. Wilde H. Rabies, 1996. Int. J. Infect. Dis. 1997, 1:135-142.
97. Winkler W.G., Fashinell T.R., Leffingwell L., Howard P., Conomy J.P. Airborne rabies transmission in a laboratory worker. JAMA 1973, 226:1219-1222.
98. World Health Organization World Health Organization expert committee on rabies: Eighth report. WHO Technical Report Series 824 1992, WHO, Geneva.
99. World Health Organization Guidelines for Dog Rabies Control, VPH/83.43 Rev. 1 1987, WHO, Geneva.
100. World Health Organization World Health Organization Recommendations on Rabies Post-Exposure Treatment and the Correct Technique of Intradermal Immunization against Rabies WHO/EMC/ZOO96.6 1997, WHO, Geneva.
101. World Health Organization World Survey of Rabies for the Year 1998. No. 34, WHO/CDS/CSR/APH/99.6 2000, WHO, Geneva.
102. World Health Organization Intradermal Application of Rabies Vaccines: Report of a WHO Consultation. Bangkok, Thailand 5-6 June 2000 WHO/CDS/CDSRAPH/2000.05 2001, WHO, Geneva.